Monocytess from patients with sepsis have a reduced capacity to produce cytokines, a state referredd to as immunoparalysis. To determine whether polymorphonuclear leukocytes (PMNL)) can be rendered hyporesponsive, PMNL from 6 healthy volunteers intravenously challengedd with lipopolysaccharide (LPS; 4 ng/kg) were stimulated ex vivo with heat-killed bacteriaa or LPS, and the release of the CXC chemokines interleukin-8, epithelial-derived neutrophill attractant-78, and growth-related oncogen-a was measured. At 1 and 2 h after LPSS administration in vivo, PMNL produced fewer CXC chemokines after stimulation with bacteriaa or LPS (all P< .05). Serum obtained 2 h after in vivo administration of LPS did not influencee chemokine production by PMNL from 6 healthy volunteers not previously exposed too LPS. Thus, intravenous injection of LPS induces a refractory state of PMNL that is not causedd by soluble factors produced in response to in vivo exposure to LPS.
Polymorphonuclearr leukocytes (PMNL) play a key role in thee pathogenesis of the sepsis syndrome [1] . Chemokines, an expandingg family of small cytokines, can influence multiple leukocytee functions [2] . The so-called CXC chemokines specificallyy act on neutrophils and have been implicated as important factorss in neutrophil-mediated inflammation. The prototypic CXCC chemokine in humans is interleukin (IL)-8; related CXCC chemokines are epithelium-derived neutrophil attractant (ENA)-788 and growth-related oncogen (GRO)-a. Of interest, PMNLL are capable of producing these CXC chemokines, enablingg them to perpetuate their own activation.
Severee sepsis is associated with a refractory state characterizedd by a reduced capacity of monocytes to produce proinflammatoryy cytokines after restimulation with endotoxin (lipopolysaccharidee [LPS]) ex vivo [3] [4] [5] . This refractory state, also termedd "LPS tolerance" or immunoparalysis, can be reproducedd by administration of low-dose LPS to healthy humans [6] [7] [8] .. Thus, whole blood or peripheral blood mononuclear cells obtainedd several hours after an in vivo injection of LPS produce fewerr proinflammatory cytokines after restimulation with LPS Thiss study was approved by the institutional ethics and review board, Academicc Medical Center, and written informed consent was obtained from alll subjects before study entry.
Financiall support: T. [6] [7] [8] . This hyporesponsiveness is at least partlyy mediated by soluble factors produced shortly after LPS injection,, because serum obtained 2 h after in vivo administrationn of LPS inhibited tumor necrosis factor (TNF) a and IL-ljSS production by LPS-stimulated whole blood from 6 healthyy donors not previously exposed to LPS [8] . Septic serum alsoo inhibits Escherichia r/o/i-induced TNF release in normal wholee blood [9, 10] .
Recentt studies suggest that not only monocytes but also PMNLL may become refractory after a severe bacterial insult. Indeed,, PMNL from patients with sepsis produced less IL-1/3 andd IL-8 after stimulation with LPS or heat-killed streptococci [11,, 12] . In the present study, we sought to determine the capacityy of PMNL isolated from healthy humans before and after aa single dose of LPS to produce IL-8, GRO-a, and ENA-78 afterr restimulation with heat-killed bacteria (Streptococcus pneumoniaepneumoniae and Pseudomonas aeruginosa) or LPS. Because a largee amount of IL-8 can be found as a cell-associated form afterr activation of PMNL [12, 13] , we further determined cellassociatedd IL-8 in these experiments. Finally, to determine whetherr soluble mediators produced in response to injection of LPSS are involved in the induction of anergy of PMNL, we assessedd the capacity of serum obtained after in vivo administrationn of LPS to reproduce the anergic state when this serum wass added to PMNL from healthy subjects not challenged with LPS S
Methods s
SubjectsSubjects and design. Six men. 22 1 years old (mean + SE), weree admitted to the Clinical Research Unit of the Academic Med- 
StimulationStimulation of PMNL.
Blood samples were drawn in sterile Vacutainerr tubes containing lithium heparin (Becton Dickinson, Rutherford,, NJ). PMNL were isolated by using Polymorphprep (Nycomed,, Torshov, Norway), as recommended in the manufacturer'ss manual. Contamination with mononuclear cells was <1% onn each occasion. Cells were resuspended in culture medium (RPMI 1640:: Gibco BRL Life Technologies, Paisley, UK) containing 5% heat-inactivatedd pooled plasma. Sterile tubes (Becton Dickinson) weree filled with 500 /iL of this cell suspension, and we added -10* PMNL/mLL and 10 uL of RPMI containing heat-killed S. pneumoniae,moniae, P. aeruginosa (both in final concentrations equivalent to 10'' cfu). or LPS (from E. coli 011LB4; Sigma, St. Louis; 10 ng/ mL).. All samples were incubated for 24 h at 37°C in 5% CO,, after whichh cells were spun down, and the supernatant was stored at -20°° until assays were performed. The cell pellet was resuspended inn 1 mL of lysis buffer containing 0.5% Triton X-100, 150 mM NaCl,, 15 mMTris. 1 mMCaCl, and 1 mMMgCl (pH 7.40), which wass subsequently subjected to 3 freeze-thaw cycles to release IL-8 fromm the cells. The solution containing the cell fractions was stored att -20°C until assays were performed.
Inn a separate series of experiments, serum obtained from the 6 volunteerss before (pre-LPS serum) and 2 h after in vivo administrationn of LPS (post-LPS serum) was pooled and subsequently incubatedd for 24 h at 37°C with PMNL from 6 other healthy volunteerss (who did not receive LPS) in the presence or absence of heat-killedd bacteria or LPS. In these experiments, 500 uh of the PMNLL solution containing 10' PMNL/mL, with different concentrationss of pre-and post-LPS serum (final concentrations 10% or 20%),, was incubated with bacteria or LPS, as described above. Sampless were handled identically to those of the first series of experiments. .
Bacteria.Bacteria.
Heat-killed S. pneumoniae (HKSP) was obtained fromm a clinical isolate (serotype D9). The bacteria were cultured overnightt in 1 L of Todd-Hewitt broth (20 h) in 5% C02 at 37°C, harvestedd by centrifugation, washed twice in pyrogen-free 0.9% NaCl,, resuspended in 10 mL of 0.9% NaCl, and heat inactivated forr 60 min at 80°C. Heat-killed P. aeruginosa (HKPA; serotype PA01)) was obtained from a clinical isolate. Bacteria were cultured, shakenn in 1 L of Luria broth (20 h) at 37°C, and heat inactivated forr 60 min at 80°C. A 500-j<L sample on a blood agar plate did nott show bacterial growth.
Assays.Assays.
IL-8, ENA-78. and GRO-a concentrations were measuredd by using specific ELISAs, according to the instructions of thee manufacturers (IL-8: Central Laboratory of the Netherlands Redd Cross Blood Transfusion Service, Amsterdam, detection limit 11 pg/mL: ENA-78: R&D Systems, Minneapolis, detection limit 15.6 pg/mL;; GRO-a: R&D Systems, detection limit 10 pg/mL). Leukocytee counts and differentials were determined by flow cytometry inn EDTA-anticoagulated blood.
StatisticalStatistical analysis.
All values are given as mean SE. Com- parisonss were done by using the Wilcoxon rank sum test. P< .05 wass considered to represent a statistically significant difference.
Results s

ResponsesResponses to intravenous injection of LPS.
Infusion of LPS inducedd an influenza-like syndrome with headache, muscle pain,, and a rise in body temperature that peaked after 3-4 h (peakk temperature, 38.8 0.2°C), Infusion of LPS caused early decliness in total leukocytes and neutrophils, which then increased.. Neutrophil numbers at the time points when PMNL weree isolated for ex vivo stimulation were 3.1 0.5 x 107mL (00 h), 0.9 0.3 X 107mL (1 h; P<.05 vs. 0 h), 4.6 + 0.55 X 10"/mL (2 h), and 5.5 0.7 x 10*/mL (24 h; 7><.05 vs. 00 h).
ExEx vivo IL-8, ENA-78, and GRO-a production by PMNL after inin vivo LPS administration.
Incubation of PMNL without LPSS or bacteria resulted in low concentrations of IL-8, ENA-78,, and GRO-a in supernatant plasma (<0.1, <0.2, and <0.3 ng/mL,, respectively; figure 1). The capacity of PMNLto release thesee chemokines in supernatant after stimulation with HKSP, HKPA,, and LPS strongly decreased after in vivo exposure to LPSS and reached a nadir after 2 h. IL-8, ENA-78, and GROaa production induced by incubation with bacteria or LPS ex vivoo returned to baseline 24 h after the in vivo administration off LPS.
EffectEffect of in vivo LPS administration
on cell-associated IL-8. Inn accordance with the decreased levels of IL-8 in supernatant, concentrationss of cell-associated [L-8 after stimulation ex vivo withh HKSP, HKPA, and LPS were lower 1 and 2 h after LPS administrationn (figure 2).
EffectEffect of pre-and post-LPS serum on chemokine production byby normal PMNL.
Neither addition of pre-LPS serum (obtainedd before LPS injection) nor addition of post-LPS serum (obtainedd 2 h after LPS injection) influenced the capacity of PMNLL isolated from healthy subjects not previously exposed too LPS to produce IL-8, ENA-78, or GRO-a after stimulation withh HKSP, HKPA, or LPS (data not shown).
Discussion n Thee phenomenon of immunoparalysis has been studied in investigationss with monocytes or whole blood. Monocytes or bloodd obtained from patients with sepsis or other systemic inflammatoryflammatory conditions or from healthy subjects exposed to lowdosee LPS have a reduced capacity to produce proinflammatory cytokiness after restimulation with LPS (3, (5) (6) (7) (8) . Not only monocytess but also PMNL from patients with sepsis display a refractoryy phenotype (i.e.. they produce less IL-1/3 and IL-8 than doo normal PMNL after stimulation with heat-killed streptococcii or LPS) [11, 12] . The present study extends these findings byy demonstrating that PMNL from healthy volunteers are renderedd anergic after an intravenous challenge with LPS. PMNL producedd less IL-8, GRO-a, and ENA-78 after stimulation with heat-killedd bacteria or LPS ex vivo after an intravenous challengee with LPS. Chemokine production was not influenced byserumm obtained from subjects after exposure to LPS, indicating thatt PMNL anergy is not induced by soluble mediators.
Off note, PMNL isolated from peripheral blood 1 and 2 h afterr LPS injection likely differed from the population present inn blood before LPS administration, because endotoxemia resultss in adhesion of PMNL to the vascular endothelium and inn subsequent release of PMNL from bone marrow. In addition, althoughh PMNL preparations were >99% pure, a theoretical possibilityy remains that contaminating monocytes influenced ourr results. Hence, the present data should be interpreted taking thesee considerations into account.
Mariee et al. [12] demonstrated that ex vivo IL-8 production byy circulating PMNL was reduced in patients with sepsis or duringg a cardiopulmonary bypass procedure. Of considerable interest,, these authors found that PMNL cannot be rendered anergicc to LPS by previous exposure to LPS in vitro. On the contrary.. PMNL pretreated with LPS in vitro had enhanced IL-88 production after reexposure to LPS [12] . These findings suggestt that anergy of PMNL is mediated via mechanisms that differr from those underlying anergy of monocytes. Indeed, monocytess can be made hyporesponsive by preexposure to LPS inn vitro [14, 15] , Our study demonstrates that in vivo exposure too LPS does render PMNL anergic for further stimulation with LPSS (and heat-killed bacteria). PMNL used in our investigation weree first challenged with LPS in their natural (in vivo) environment-thatt is, in close contact with other blood components andd the endothelium before being stimulated ex vivo with bacteriaa or LPS. Because preincubation of PMNL with LPS in vitroo does not result in PMNL hyporesponsiveness [12] , these dataa suggest that LPS does not induce an anergic state in PMNLL in the absence of other cell types or soluble mediators.
Thee capacity to produce PMNL-associated IL-8 also decreasedd after intravenous injection of LPS. Marie et al. [12] had aa similar finding in patients after cardiopulmonary bypass surgery,, but not in patients with sepsis. Clearly, additional studies aree warranted to evaluate possible mechanisms underlying the discrepanciess between IL-8 that is released and IL-8 that remainss cell-associated after stimulation of isolated PMNL.
Wee were interested in learning whether soluble factors producedd after in vivo administration of LPS are involved in the hyporesponsivenesss of PMNL, considering, first, that the LPS hyporesponsivenesss of monocytes can be reproduced in part by additionn of serum from patients with sepsis [9, 10] or from healthyy subjects injected with LPS [8] , and, second, that LPS cannott induce PMNL anergy when incubated with isolated PMNLL in vitro (see above) [12] . The results of our experiments, inn which we stimulated PMNL from healthy volunteers not exposedd to LPS, in the absence and presence of serum obtained fromm LPS-challenged volunteers, suggest that soluble factors doo not play a role in the induction of anergy of PMNL after exposuree to LPS in vivo. This finding further supports the notionn that PMNL anergy is mediated via pathways that, at least inn part, differ from those involved in monocyte anergy.
